Xiaomeng Cui
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Increased risk of malignancy and osteoporosis in primary Sjögren's syndrome with thyroid diseases: potential implication from T cells.
Journal: Rheumatology (Oxford, England)
Published: May 01, 2024
Transition Metal Functionalized C30N12S6 as High-Performance Trifunctional Catalysts with Integrated Descriptors toward Hydrogen Evolution, Oxygen Evolution, and Oxygen Reduction Reactions: A Case of High-Throughput First-Principles Screening within the Framework of TM-N2@C30N10S6.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: December 25, 2023
Kagome-like BiP3 Monolayer: An Emerging Quasi-Direct Auxetic Semiconductor Coupled with High Anisotropic Mobility toward Visible-Light-Driven Photoelectrocatalytic pH-Robust Overall Water-Splitting.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: August 31, 2023
The role of plateletcrit in Takayasu arteritis: A potential biomarker for disease activity and 6-month treatment response.
Journal: International journal of rheumatic diseases
Published: July 15, 2023
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
Journal: Frontiers in immunology
Published: December 27, 2020
Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population.
Journal: Joint bone spine
Published: November 15, 2020
Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis.
Journal: Therapeutic advances in chronic disease
Published: August 06, 2020
Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China.
Journal: Arthritis research & therapy
Published: February 02, 2020
The value of interleukin-6 in predicting disease relapse for Takayasu arteritis during 2-year follow-up.
Journal: Clinical rheumatology
Published: January 15, 2020
Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study.
Journal: Therapeutic advances in chronic disease
Published: July 22, 2019
CYR61/TGF-β axis promotes adventitial fibrosis of Takayasu's arteritis in the IL-17 mediated inflammatory microenvironment.
Journal: Clinical and experimental rheumatology
Published: July 08, 2019
The potential role of leflunomide in inhibiting vascular fibrosis by down-regulating type-II macrophages in Takayasu's arteritis.
Journal: Clinical and experimental rheumatology
Published: June 02, 2019
Last Updated: 09/26/2026